Home LiteratureArticle Details
PMID: 8415656 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Mice with reduced levels of p53 protein exhibit the testicular giant-cell degenerative syndrome.

Rotter V, Schwartz D, Almon E, Goldfinger N, Kapon A, Meshorer A, Donehower LA, Levine AJ

Abstract

Transgenic mice which carry hybrid p53 promoter-chloramphenicol acetyltransferase (CAT) transgenes were found to express CAT enzymatic activity predominantly in the testes. Endogenous levels of p53 mRNA and protein were lower than in the nontransgenic control mice. The various p53 promoter-CAT transgenic mice exhibited in their testes multinucleated giant cells, a degenerative syndrome resulting presumably from the inability of the tetraploid primary spermatocytes to complete meiotic division. The giant-cell degenerative syndrome was also observed in some genetic strains of homozygous p53 null mice. In view of the hypothesis that p53 plays a role in DNA repair mechanisms, it is tempting to speculate that the physiological function of p53 that is specifically expressed in the meiotic pachytene phase of spermatogenesis is to allow adequate time for the DNA reshuffling and repair events which occur at this phase to be properly completed. Primary spermatocytes which have reduced p53 levels are probably impaired with respect to DNA repair, thus leading to the development of genetically defective giant cells that do not mature.

MeSH Terms
Animals Chloramphenicol O-Acetyltransferase/biosynthesis,genetics Gene Expression Genes, p53 Homozygote Humans Male Mice Mice, Transgenic Promoter Regions, Genetic RNA, Messenger/analysis,metabolism Recombinant Fusion Proteins/biosynthesis Restriction Mapping Syndrome Testis/pathology Tumor Suppressor Protein p53/biosynthesis
Chemicals
RNA, Messenger Recombinant Fusion Proteins Tumor Suppressor Protein p53 Chloramphenicol O-Acetyltransferase
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Rotter V
Department of Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Schwartz D
Almon E
Goldfinger N
Kapon A
Meshorer A
Donehower L A
Levine A J
References (46)
46 references, click to expand
  1. Expression from the murine p53 promoter is mediated by factor binding to a downstream helix-loop-helix recognition motif.
    Proc Natl Acad Sci U S A. 1991 May 15;88(10):4128-32 PMID: 1851994
  2. Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system.
    Cell. 1992 May 29;69(5):737-49 PMID: 1317267
  3. p53 mutations in human cancers.
    Science. 1991 Jul 5;253(5015):49-53 PMID: 1905840
  4. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6.
    Nature. 1991 Jul 25;352(6333):345-7 PMID: 1852210
  5. Levels of p53 protein increase with maturation in human hematopoietic cells.
    Cancer Res. 1991 Aug 15;51(16):4279-86 PMID: 1868448
  6. Alterations in tumor development in vivo mediated by expression of wild type or mutant p53 proteins.
    Cancer Res. 1991 Oct 1;51(19):5232-7 PMID: 1717142
  7. Involvement of wild-type p53 in pre-B-cell differentiation in vitro.
    Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):8982-6 PMID: 1924360
  8. An embryo protein induced by SV40 virus transformation of mouse cells.
    Nature. 1980 Dec 25;288(5792):722-4 PMID: 6256642
  9. Increased concentration of an apparently identical cellular protein in cells transformed by either Abelson murine leukemia virus or other transforming agents.
    J Virol. 1981 Apr;38(1):336-46 PMID: 6264107
  10. Monoclonal antibodies specific for simian virus 40 tumor antigens.
    J Virol. 1981 Sep;39(3):861-9 PMID: 6169844
  11. Introduction of a mu immunoglobulin gene into the mouse germ line: specific expression in lymphoid cells and synthesis of functional antibody.
    Cell. 1984 Oct;38(3):647-58 PMID: 6091894
  12. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells.
    Mol Cell Biol. 1984 Sep;4(9):1689-94 PMID: 6092932
  13. Lens-specific expression and developmental regulation of the bacterial chloramphenicol acetyltransferase gene driven by the murine alpha A-crystallin promoter in transgenic mice.
    Proc Natl Acad Sci U S A. 1985 Dec;82(23):7815-9 PMID: 3865198
  14. DNA synthesis at selective sites during pachytene in mouse spermatocytes.
    Chromosoma. 1986;93(6):529-36 PMID: 3731943
  15. p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors.
    Mol Cell Biol. 1985 Oct;5(10):2851-5 PMID: 3915536
  16. p53 and DNA polymerase alpha compete for binding to SV40 T antigen.
    Nature. 1987 Oct 1-7;329(6138):456-8 PMID: 3309672
  17. Mouse p53 inhibits SV40 origin-dependent DNA replication.
    Nature. 1987 Oct 1-7;329(6138):458-60 PMID: 2821401
  18. DNA double-strand damage and repair following gamma-irradiation in isolated spermatogenic cells.
    Mutat Res. 1988 Nov;194(3):183-91 PMID: 3185581
  19. Cancer. p53, guardian of the genome.
    Nature. 1992 Jul 2;358(6381):15-6 PMID: 1614522
  20. Expression of p53 during mouse embryogenesis.
    Development. 1991 Nov;113(3):857-65 PMID: 1821855
  21. Wild-type p53 is a cell cycle checkpoint determinant following irradiation.
    Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7491-5 PMID: 1323840
  22. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.
    Cell. 1992 Sep 18;70(6):923-35 PMID: 1356076
  23. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development.
    Cell. 1992 Oct 30;71(3):383-90 PMID: 1330322
  24. Testicular tissue-specific expression of the p53 suppressor gene.
    Dev Biol. 1993 Mar;156(1):107-16 PMID: 7680625
  25. Expression of p53 protein in spermatogenesis is confined to the tetraploid pachytene primary spermatocytes.
    Oncogene. 1993 Jun;8(6):1487-94 PMID: 8502474
  26. The murine p53 protein blocks replication of SV40 DNA in vitro by inhibiting the initiation functions of SV40 large T antigen.
    Cell. 1989 May 5;57(3):379-92 PMID: 2541911
  27. Two promoters that map to 5'-sequences of the human p53 gene are differentially regulated during terminal differentiation of human myeloid leukemic cells.
    Oncogene. 1989 Aug;4(8):945-53 PMID: 2668845
  28. p53: oncogene or anti-oncogene?
    Genes Dev. 1990 Jan;4(1):1-8 PMID: 2137806
  29. Oncogene v-jun modulates DNA replication.
    Oncogene. 1990 Jul;5(7):1055-8 PMID: 2165232
  30. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.
    Proc Natl Acad Sci U S A. 1990 Aug;87(16):6166-70 PMID: 2143581
  31. Ectopic expression of chloramphenicol acetyltransferase (CAT) in the cerebellum in mice transgenic for a carbonic anhydrase II promoter-CAT construct that is without apparent phenotypic effect.
    Mol Reprod Dev. 1990 Oct;27(2):102-9 PMID: 2123391
  32. Induction of growth arrest by a temperature-sensitive p53 mutant is correlated with increased nuclear localization and decreased stability of the protein.
    Mol Cell Biol. 1991 Jan;11(1):582-5 PMID: 1986251
  33. Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells.
    Oncogene. 1990 Nov;5(11):1707-11 PMID: 2267137
  34. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein.
    Genes Dev. 1991 Feb;5(2):151-9 PMID: 1995413
  35. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice.
    Cell. 1991 Feb 22;64(4):693-702 PMID: 1997203
  36. Subtle cerebellar phenotype in mice homozygous for a targeted deletion of the En-2 homeobox.
    Science. 1991 Mar 8;251(4998):1239-43 PMID: 1672471
  37. Properties and applications of human DNA repair genes.
    Mutat Res. 1991 Apr;247(2):213-9 PMID: 2011139
  38. A mediator required for activation of RNA polymerase II transcription in vitro.
    Nature. 1991 Apr 4;350(6317):436-8 PMID: 2011193
  39. Transcriptional interference between the EBV transcription factors EB1 and R: both DNA-binding and activation domains of EB1 are required.
    Nucleic Acids Res. 1991 Mar 25;19(6):1251-8 PMID: 1851554
  40. Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1.
    Cell. 1991 May 17;65(4):551-68 PMID: 1851669
  41. Participation of p53 protein in the cellular response to DNA damage.
    Cancer Res. 1991 Dec 1;51(23 Pt 1):6304-11 PMID: 1933891
  42. DNA polymerase-beta and poly(ADP)ribose polymerase mRNAs are differentially expressed during the development of male germinal cells.
    Biol Reprod. 1992 Feb;46(2):201-7 PMID: 1536896
  43. Yeast genes involved in DNA-repair processes: new looks on old faces.
    Mol Microbiol. 1991 Oct;5(10):2303-10 PMID: 1665193
  44. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.
    Nature. 1992 Mar 19;356(6366):215-21 PMID: 1552940
  45. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.
    Proc Natl Acad Sci U S A. 1992 May 15;89(10):4495-9 PMID: 1584781
  46. The p53 tumour suppressor gene.
    Nature. 1991 Jun 6;351(6326):453-6 PMID: 2046748
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1993-10-01
Pages
9075-9
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC47504
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]